Featured Post

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...

Tuesday, April 4, 2017

Exclusive: Progenics CEO Talks Regulatory Climate, Positive Trials For Ultra-Orphan Azedra

http://ift.tt/eA8V8J

From healthcare to finance to natural resources, everyone is reeling from federal administration shakeups and their various market implications. But Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) CEO Mark Baker is unconcerned by leadership and regulatory changes at the U.S. Food and Drug Administration.

read more



April 04, 2017 at 12:05AM

http://ift.tt/2oRGs1v

from Elizabeth Balboa

http://ift.tt/2oRGs1v
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)